CONCORD BIOTECH LTD Q3 RESULTS
Q3 results this week: RIL, Infosys, HCL Tech, Jio Finance, Kotak Mahindra Bank among 101 companies to announce earnings
The Q3 earnings season continues with major companies such as HCL Technologies, Infosys, Axis Bank, Reliance Industries, and Wipro reporting their results this week. Key dates include announcements from Anand Rathi Wealth and Tata Elxsi on January 13, followed by HDFC Life Insurance and Infosys on January 16. Market participants await insights from these reports to gauge future trends.
ITI Ltd, Easy Trip Planners among 10 stocks that defied today’s market sell-off
Sensex and Nifty fell over 1.6%, but select stocks gained despite the selloff. ITI Ltd surged 20%, healthcare stocks rallied on virus-related news, and Titan rose 2.3% on strong Q3 growth. ICICI Bank provided benchmark support.
Q2 results today: Vodafone Idea, Eicher Motors among 650 companies to announce earnings on Wednesday
Vodafone Idea is expected to report a narrower consolidated loss for the second quarter, driven by revenue growth and improved ARPU. Analysts predict a loss between Rs 6300-6400 crore, with revenue rising 5% year-on-year. Subscriber base may decline, but ARPU is projected to reach Rs 156-159.
Q2 results this week: Hyundai, Nykaa, Vodafone Idea among 2515 companies to announce earnings
Over 2500 companies, including prominent names like ONGC, Hindalco, and Hero MotoCorp, are set to release their second-quarter earnings this week. Early reports suggest muted results, with analysts predicting the slowest growth in over four years due to a marginal 2% rise in Nifty earnings.
Biocon Q1 Results: Net Jumps 6-fold to Rs 660 cr on one-time gain
Biocon's net profit for Q1FY25 surged to ₹660 crore, up from ₹101 crore the previous year, primarily due to a one-time gain from selling Biocon Biologics' domestic branded formulation business. Revenue remained flat at ₹3,433 crore. Core EBITDA saw a decline, although overall EBITDA improved significantly due to the one-off gain.
Ajanta Pharma buyback: Last day today to buy shares for Rs 285 crore special situation opportunity
Ajanta Pharma has set May 30 as the record date for its Rs 285 crore share buyback,. The buyback, at a premium of 12.6%, targets 10,28,881 equity shares, constituting 8.34% of the company's aggregate equity. Amidst strong financials, the company reported a 66% YoY growth in PAT and a 20% YoY increase in revenue in its Q4 results.
- Go To Page 1
Concord Biotech stock slips over 5% after Rs 519 crore worth of shares change hands
Shares of Concord Biotech fell 5.3% on BSE due to a large block deal where Ontario Inc. sold a 3.4% stake at a discount, impacting stock performance.
Q4 results today: ITC, IndiGo among 181 companies to announce earnings on Thursday
181 companies, including IndiGo and ITC, will announce their quarterly earnings for Jan-Mar 2024. IndiGo is expected to post healthy earnings, while ITC may see muted revenue growth.
Q4 results this week: ITC, ONGC, Sun Pharma, Nykaa, Ircon International and IRFC
ITC, ONGC, IRFC, Ircon International, BHEL, BEL, Sun Pharma, Nykaa, Tata Investment Corporation, Hindalco, Ashok Leyland, and Divi's lab will be releasing their March quarter report cards this week.
Piramal Pharma shares soar 11%, hit 52-week high after Q4 profit jumps 102% YoY
The company's revenue from operations increased by 18% to Rs 2,552.4 crore as against Rs 2,163.6 crore in the corresponding period of the preceding fiscal.
Q3 results today: Zomato, LIC, Grasim among 270 companies to announce earnings
Q3 results today: As for Trent, the fashion retailer posted a 124% jump in consolidated net profit to Rs 374.36 crore versus PAT of Rs 167 crore in the year-ago period.
Syngene International Q3 Results: Net profit rises 2% YoY to Rs 112 crore, company revises revenue guidance
The rise in Q3 profit of Syngene International was led by dedicated centres and development and manufacturing services, even as discovery services business remained soft. The third quarter revenue from operations rose 9% YoY to Rs. 854 crore. The earnings before interest, tax, depreciation and ammortisation (EBITDA) rose 5% YoY to Rs. 261 crore in Q3FY24. The EBITDA margin dropped 100 basis points YoY to 30%.
Q2 results this week: Adani Ports, Tata Power, LIC, RVNL, M&M and others
Power Grid, Shree Cements, Trent, Zydus Lifesciences, Info Edge (India), Indian Railway Catering & Tourism Corporation, Cummins India, Alkem Laboratories, UNO Minda, Prestige Estates Projects, among others will release their Q2 earnings on November 7
D-Street debuts rake in $1.77 bn in Q3; momentum to continue till general elections
The buzzing Indian initial public offer (IPO) market is the best globally, says a report by Ernst & Young. In the September quarter, 21 mainboard IPOs raised as much as $1.77 billion – marking a 3.7x growth in amount rates and 4.2x growth in number of deals. The SME IPO market too recorded significant success by raising $165.7 million via 48 IPOs in the third quarter of 2023. And this momentum will go on for another another, predicts the consulting firm’s IPO trends report.
3 sectors on radar where we will buy on 15-20-25-40% fall : Vinay Jaising
India's dependence on global markets for liquidity has reduced, with retail India providing strong inflows. rising US yields will not have a severe impact on India, as the country is more resilient and has seen higher interest rates in the past. Indian markets may be sideways in the medium term, but quarterly results and earnings growth will drive market performance. JM Financial Services is researching and keeping an eye on opportunities in the finsumption, capex, and Make in India sectors.
Concord Biotech’s IPO subscribed almost 25x with good interest from QIBs
Ahmedabad-based pharma company Concord Biotech received a tepid response from investors on the first day of opening its public issue. Only 58% of the issue was subscribed as of 5 pm on Friday. While the non-institutional investor portion was subscribed fully, 72% of the retail portion was subscribed. Qualified institutional investors (QIBs) barely placed any bids.
Q1 results this week: Tata Steel, L&T, Axis Bank, Bajaj Finance, Tech Mahindra, Tata Motors, and others
Larsen & Toubro (L&T), Asian Paints, Tata Motors, Bajaj Auto, SBI Life Insurance Company, Jubilant FoodWorks, KPIT Technologies, Dixon Technologies, Suzlon Energy, among others will report Q1 results on July 25
For risk takers: 5 smallcap stocks that have beaten volatile markets can rise up to 52%
As Nifty comes closer to form a new high, more small cap stocks are joining the party. Right from a power and a diagnostic major to an engineering company are coming on the list. ET screener powered by Refinitiv’s Stock Report Plus applies different algorithms & filters to all BSE and NSE stocks, and lists stocks which fulfill the various criteria as specified into the algorithms & filters to find those which might help navigate the stock market.
Stocks in news: Kotak Bank, Ultratech Cement, Varun Beverages, Tata Steel, Ambuja Cements, Bank of Baroda, NDTV
UltraTech Cement's consolidated net profit fell 36% to Rs 1,666 crore for the fourth quarter ended March. Revenue from operations during the fourth quarter rose 18% to Rs 18,562 crore.
Can Sun Pharma's quarterly show reinforce investor confidence in stock?
The company intends to increase its specialty drug portfolio in its core areas of dermatology and ophthalmology. This comes at a time when the company’s generic business continues to face pricing pressure. The company’s Halol plant, receiving an import alert from the USFDA earlier in December, remains a challenge for Sun.
Laurus Labs Q3 Results: Net profit rises 32% to Rs 203 crore
Dr. Satyanarayana Chava, founder and chief executive officer of Laurus Labs said the company is on path of diversification and strengthening non-ARV portfolio and building niche capabilities in specialty chemicals, animal health, agri-chemicals and biotech.
Q3 results this week: L&T, Bajaj Finserv, Sun Pharma, Tech Mahindra, Ashok Leyland and others
Results that will be out on January 30 include Larsen & Toubro, Bajaj Finserv, Tech Mahindra, Bharat Petroleum Corporation, Bajaj Holdings & Investment, GAIL, SRF, Punjab National Bank, REC, Laurus Labs, IIFL Finance, Trident, Exide Industries, Nippon Life India Asset Management, Mazagon Dock Shipbuilders, Welspun as well as Inox Leisure.
Corporate Radar: Orient Electric to turn ex-dividend; JSPL, LTTS Q1 results; AGMs, and more
Today is the record date for Radhe Developers to ascertain the eligibility of shareholders entitled to bonus shares of the company in the proportion of 1:1. Today is also the record date for Shankar Lal Rampal Dye-Chem to ascertain the eligibility of shareholders entitled to issue of bonus shares of the company in the proportion of 2:1.
Corporate Radar: Titan to turn ex-dividend; TCS Q1 results; Havells India AGM & more
Tata Consultancy Services, MMTC, Kohinoor Foods, Shrenik, Brahmaputra Infrastructure, Morarka Finance and Spectrum Foods are among companies that will announce their quarterly earnings today.
Up 100% in 2 years! Can this specialty chemical stock continue its winning run?
Domestic brokerage YES Securities sees continuation in growth momentum on the back of multiple acquisitions, along with improvement in margins, and thus, has maintained its buy rating on the stock.
Corporate Radar: Bonuses, dividends, Q4 results & more
Godrej Consumer Products, Dr. Reddy's Laboratories, Gland Pharma, Bosch, Ashok Leyland and HPCL are among companies which will announce their quarterly earnings today.
Cadila Healthcare Q3 Results: Firm posts 5% decline in profit at Rs 500 cr
Consolidated total revenue from operations stood at Rs 3,655 crore during the quarter under review as compared to Rs 3,633 crore in the year-ago quarter, it added.
Hester Biosciences Q1 results: Net profit jumps two-fold to Rs 11 cr
Revenue from operations stood at Rs 60.18 crore in the quarter under review. It was Rs 39.85 crore in the same period a year ago, it added.
Q1 results, vaccine progress, Rossari Biotech listing among 7 factors guiding market this week
The 30-share Sensex climbed 425.81 points or 1.16 per cent to 37,020.14 points in the week, while the 50-share Nifty rose 133.65 or 1.24 per cent to 10,901.70 points.
Load More
